Seenu Hariprasad to Treatment Outcome
This is a "connection" page, showing publications Seenu Hariprasad has written about Treatment Outcome.
Connection Strength
0.333
-
Abicipar pegol for neovascular age-related macular degeneration. Expert Opin Biol Ther. 2020 09; 20(9):999-1008.
Score: 0.073
-
DRCR Protocol-T: Reconciling 1- and 2-Year Data for Managing Diabetic Macular Edema. Ophthalmic Surg Lasers Imaging Retina. 2016 Apr 01; 47(4):308-12.
Score: 0.054
-
Outcomes of chronic macular hole surgical repair. Indian J Ophthalmol. 2014 Jul; 62(7):795-8.
Score: 0.048
-
Voriconazole in the treatment of fungal eye infections: a review of current literature. Br J Ophthalmol. 2008 Jul; 92(7):871-8.
Score: 0.032
-
Cystoid and diabetic macular edema treated with nepafenac 0.1%. J Ocul Pharmacol Ther. 2007 Dec; 23(6):585-90.
Score: 0.030
-
Suprachoroidal Injection of Triamcinolone Acetonide Injectable Suspension for the Treatment of Macular Edema Associated With Uveitis in the United States: A Cost-Effectiveness Analysis. Value Health. 2022 10; 25(10):1705-1716.
Score: 0.021
-
Dexamethasone and Anti-VEGF Combination Therapy for the Treatment of Diabetic Macular Edema. Ophthalmic Surg Lasers Imaging Retina. 2019 01 01; 50(1):4-7.
Score: 0.016
-
Early Response to Intravitreal Dexamethasone Implant Therapy in Diabetic Macular Edema May Predict Visual Outcome. Am J Ophthalmol. 2017 Dec; 184:121-128.
Score: 0.015
-
Treatment Burden in Neovascular AMD:Visual Acuity Outcomes are Associated With Anti-VEGF Injection Frequency. Ophthalmic Surg Lasers Imaging Retina. 2017 10 01; 48(10):780-784.
Score: 0.015
-
Evaluation of very high- and very low-dose intravitreal aflibercept in patients with neovascular age-related macular degeneration. J Ocul Pharmacol Ther. 2012 Dec; 28(6):581-8.
Score: 0.010
-
Sustained delivery fluocinolone acetonide vitreous inserts provide benefit for at least 3 years in patients with diabetic macular edema. Ophthalmology. 2012 Oct; 119(10):2125-32.
Score: 0.010
-
A phase I study of intravitreal vascular endothelial growth factor trap-eye in patients with neovascular age-related macular degeneration. Ophthalmology. 2009 Nov; 116(11):2141-8.e1.
Score: 0.009